Vaccine therapy for cutaneous T-cell lymphoma-Reference-Cited by-同舟云学术

Vaccine therapy for cutaneous T-cell lymphoma

Published:2003-12 Issue:6 Volume:17 Page:1467-1474
ISSN:0889-8588
Container-title:Hematology/Oncology Clinics of North America
language:en
Short-container-title:Hematology/Oncology Clinics of North America

Author:

Seo Naohiro,Furukawa Fukumi,Tokura Yoshiki,Takigawa Masahiro

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference25 articles.

1. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity;Celluzzi;J Exp Med,1996

2. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo;Paglia;J Exp Med,1996

3. Dendritic cells as stimulator cells of MHC class I-restricted immune responses;Elbe;Adv Exp Med Biol,1995

4. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy;Kirk;Cancer Res,2001

5. CD40–CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes;Moodycliffe;J Exp Med,2000

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biogenic nanoparticles as immunomodulator for tumor treatment;WIREs Nanomedicine and Nanobiotechnology;2020-05-28

2. Intercellular Crosstalk Via Extracellular Vesicles in Tumor Milieu as Emerging Therapies for Cancer Progression;Current Pharmaceutical Design;2019-09-04

3. Exosome‐mediated regulation of tumor immunology;Cancer Science;2018-08

4. Updates on the use of vaccines in dermatological conditions;Indian Journal of Dermatology, Venereology and Leprology;2018

5. Molecular Basis of Skin Disease;Molecular Pathology;2018